Follows adults with tuberculosis to study long-term lung health
Follows adults in treatment for, or treated for, tuberculosis to track lung health.
Plain-language title generated from the registry record
Registry title: LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Department of Internal Medicine, Yonsei University College of Medicine Division of Pulmonology, Severance Hospital, Yonsei University Health SystemSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yonsei University
- Trial code
- NCT06946784
- Record updated
- 27 April 2025
- Original description
This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.Read full original descriptionShow less
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.
Inclusion: Age ≥19 years; Diagnosed with pulmonary TB and either initiating or undergoing treatment or history of treated pulmonary TB.
Exclusion: Age <19 years; Extrapulmonary TB without lung involvement; Refusal to provide informed consent.